321 related articles for article (PubMed ID: 30097127)
1. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
[TBL] [Abstract][Full Text] [Related]
2. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.
Su YK; Bamodu OA; Tzeng YM; Hsiao M; Yeh CT; Lin CM
Phytomedicine; 2019 Aug; 61():152840. PubMed ID: 31035045
[TBL] [Abstract][Full Text] [Related]
3. Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK/STAT signaling pathway.
Liu SC; Huang CM; Bamodu OA; Lin CS; Liu BL; Tzeng YM; Tsai JT; Lee WH; Chen TM
Phytomedicine; 2019 Mar; 56():269-278. PubMed ID: 30668347
[TBL] [Abstract][Full Text] [Related]
4. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.
Lu KT; Wang BY; Chi WY; Chang-Chien J; Yang JJ; Lee HT; Tzeng YM; Chang WW
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27136586
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
6. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Maiti TK; Bhutia SK
Tumour Biol; 2017 May; 39(5):1010428317701634. PubMed ID: 28459216
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Cancer Stemness by Novel Diterpenoid Ovatodiolide Inhibits Hepatic Cancer Stem Cell-Like Traits by Repressing Wnt/[Formula: see text]-Catenin Signaling.
Liu M; Bamodu OA; Kuo KT; Lee WH; Lin YK; Wu ATH; M H; Tzeng YM; Yeh CT; Tsai JT
Am J Chin Med; 2018; 46(4):891-910. PubMed ID: 29792038
[TBL] [Abstract][Full Text] [Related]
8. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
9. Phenethyl isothiocyanate suppresses cancer stem cell properties in vitro and in a xenograft model.
Yun JH; Kim KA; Yoo G; Kim SY; Shin JM; Kim JH; Jung SH; Kim J; Nho CW
Phytomedicine; 2017 Jul; 30():42-49. PubMed ID: 28545668
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
[TBL] [Abstract][Full Text] [Related]
12. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin B exhibits antitumor effects on CD133+ HepG2 liver cancer stem cells by inhibiting JAK2/STAT3 signaling pathway.
Wang X; Bai Y; Yan X; Li J; Lin B; Dai L; Xu C; Li H; Li D; Yang T; Zhang T
Anticancer Drugs; 2021 Jun; 32(5):548-557. PubMed ID: 33675610
[TBL] [Abstract][Full Text] [Related]
16. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
17. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
18. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway.
Wu L; Guo L; Liang Y; Liu X; Jiang L; Wang L
Oncol Rep; 2015 Dec; 34(6):3311-7. PubMed ID: 26397387
[TBL] [Abstract][Full Text] [Related]
20. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
